RADiant provides surface radiation therapy treatment for a wide range of superficial skin conditions, including basal and squamous cell carcinoma. RADiant is the first dual-modality system designed for dermatologists to offer both electronic brachytherapy and superficial radiation therapy. In this webinar, Dr. Steven Davis, medical director of The Dermatology & Laser Center of San Antonio, describes these modalities, patient selection criteria, and outcomes. Dr. Davis has performed more than 25,000 skin cancer operations and chose Xstrahl’s RADiant system to expand his practice.
Maui Derm Hawaii 2025 to Feature Xstrahl’s Dual Modality Treatment Solution for Dermatologists
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will feature Radiant Aura at the Maui Derm Hawaii 2025 meeting, January 20-24, 2025. Radiant Aura is a low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring.
